Centers for Disease Control and Prevention (CDC)

UCLA Fielding School of Public Health faculty experts available for media covering novel coronavirus (COVID-19)

Feature

Recognize an overdose, save a life

January 26, 2020 sarah Jonas 0 Comments Alcohol Poisoning, alternative pain management, Centers for Disease Control and Prevention (CDC), Chronic Pain, Naloxone, Opioid Epidemic, opioid overdose, Opioid Overdose Deaths, Pain Management, Pain Medicine, Patient Safety, Resuscitation

Every day nearly 200 people die from an overdose of drugs or from alcohol poisoning, with opioids responsible for the majority. Recognizing the signs and knowing how to respond to medical emergencies, including carrying and administering naloxone in cases of opioid overdose, can save lives says the ASA.

Expert Pitch

UCLA Public Health Experts on Coronavirus and related issues

January 20, 2020 sarah Jonas 0 Comments Centers for Disease Control and Prevention (CDC), Coronavirus, Public Health, World Health Organization

Policy

FY 2020 Spending Bill Funds Critical Initiatives While Neglecting Urgent Priorities

December 19, 2019 sarah Jonas 0 Comments Biomedical Advanced Research and Development Authority, CDC, Centers for Disease Control and Prevention (CDC), Congress, HIV, HIV Medicine Association, HIVMA, Idsa, Infectious Diseases, Infectious Diseases Society Of America, NIH

The spending bill passed today is a welcome step forward. Allocations in the bill will strengthen public health and research efforts during the year ahead and will provide critical support for important goals. At the same time, the legislation in its final form also brings inadequate responses to current and urgent challenges with the potential for long-term and costly consequences.

Policy

House Drug Pricing Bill Serves Patients, Public Health

December 12, 2019 sarah Jonas 0 Comments Biomedical Advanced Research and Development Authority, CDC, Centers for Disease Control and Prevention (CDC), Congress, Hepatitis C, HIV, HIV Medicine Association, HIVMA, Idsa, Infectious Diseases Society Of America, National Institutes Of Health (NIH), NIH

H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act passed by the House of Representatives today introduces critically needed and significant steps to reduce costs and improve access to life-saving therapies for conditions including HIV and hepatitis C. Importantly, the legislation also brings essential resources to combat antibiotic resistance, find and develop new infection fighting drugs and bring them to market. The balanced approach of this legislation will serve patients and public health.